Amyloid β1‐40 Predicts Long‐Term Mortality Rate in Patients With Acute Myocardial Infarction

Amyloid β1‐40 Predicts Long‐Term Mortality Rate in Patients With Acute Myocardial Infarction

Background Amyloid β1‐40 (Aβ1‐40) contributes to atherosclerosis, being involved in plaque formation and destabilization. The prognostic role of Aβ1‐40 in patients with acute myocardial infarction is currently limited to non–ST‐segment–elevation myocardial infarction (NSTEMI). We examined the progno...

Full description

Saved in:

Bibliographic Details
Main Authors:	Aneta Aleksova, Alessandra Lucia Fluca, Alessandro Pierri, Giulia Barbati, Antonio Paolo Beltrami, Laura Padoan, Enzo Merro, Maria Marketou, Donna Zwas, Stefano D'Errico, Gianfranco Sinagra, Milijana Janjusevic
Format:	Article
Language:	English
Published:	Wiley 2025-04-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	acute myocardial infarction amyloid β1‐40 death NSTEMI risk stratification STEMI
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.124.035620
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Short‐Term Associations Between Ambient Ozone and Acute Myocardial Infarction Onset Among Younger Patients: Results From the VIRGO Study
by: Siqi Zhang, et al.
Published: (2025-02-01)

Plasma Exosomal Proteomics Identifies Differentially Expressed Proteins as Biomarkers for Acute Myocardial Infarction
by: Jie Zhou, et al.
Published: (2025-04-01)

Role of Nutritional Status in Acute Coronary Syndrome Patients with Diabetes
by: Özlem Seçen, et al.
Published: (2025-04-01)

THE DIFFERENCES IN TROPONIN I AND CK-MB VALUES IN ACUTE MYOCARDIAL INFARCTION PATIENTS WITH ST ELEVATION AND WITHOUT ST ELEVATION
by: Paulus Rio Kurniawan, et al.
Published: (2021-03-01)

Impact of smoking on procedural outcomes and all-cause mortality following acute myocardial infarction: A misleading early-stage pseudoparadox with ultimately reduced survival
by: Mohammed Abusharekh, et al.
Published: (2024-12-01)

Management of Acute Coronary Syndrome in the COVID Era
by: Ronak Bahuva, et al.
Published: (2021-12-01)

Gender related outcome differences in off-pump coronary artery bypass grafting
by: Riswan Akram, et al.
Published: (2025-08-01)

Acute myocardial infarction at a district hospital in KwaZulu-Natal – Management and outcomes
by: Zakariya Badat, et al.
Published: (2022-06-01)

Vascular senescence and atherosclerotic plaque vulnerability: investigating the telomere-mitochondria crosstalk—rationale and design of the VICTORIA Study
by: Jonica Campolo, et al.
Published: (2024-07-01)

Watchful waiting in laryngo‐tracheobronchial amyloid: A case report
by: Dylan Beinart, et al.
Published: (2024-11-01)

Invasive Versus Conservative Management Among Older Adult Patients With Non–ST‐Segment–Elevation Myocardial Infarction: A Meta‐Analysis of Randomized Controlled Trials
by: Mohamed Hamed, et al.
Published: (2025-07-01)

The role of neuroinflammation in cerebral amyloid angiopathy
by: Hilde van den Brink, et al.
Published: (2024-12-01)

The value of CD47 and CAP1 levels in early diagnosis and MACE prediction for patients with non-ST-segment elevation myocardial infarction
by: Mingyang Li, et al.
Published: (2025-07-01)

Sinoatrial Nodal Artery Arising from the Right Posterolateral Artery: A Rare Anatomical Variant
by: Parviz-Ali Lotfian, et al.
Published: (2022-09-01)

Clinical performance validation and four diagnostic strategy assessments of high-sensitivity troponin I assays
by: Junyi Wu, et al.
Published: (2025-04-01)

Sex-related disparities in incidence and in-hospital outcomes of Atrial fibrillation complicated by non-ST-elevation myocardial infarction from the national in-sample database (2016–2022)
by: Farah Yasmin, et al.
Published: (2025-08-01)

Occlusion of Two Coronary Arteries Simultaneously
by: Amjed Sheet
Published: (2022-12-01)

Solving the Amyloid Paradox: Unveiling the Complex Pathogenicity of Amyloid Fibrils
by: Maksim I. Sulatsky, et al.
Published: (2025-07-01)

Prognostic significance of a combination of novel biomarkers in the long-term stratification of adverse outcomes in patients with ST-segment elevation myocardial infarction
by: D. F. Gareeva, et al.
Published: (2020-12-01)

Serum amyloid A1 (SAA1) protein in human colostrum
by: George H. Sack Jr, et al.
Published: (2018-03-01)

Long-term follow-up of retinal amyloid angiopathy in a large Chinese family with hereditary amyloid transthyretin
by: Jiangning Xu, et al.
Published: (2025-04-01)

A Pilot Study on Blood Concentration of β-Amyloid (40 and 42) and Phospho-Tau 181 in Horses
by: Valentina Gazzano, et al.
Published: (2025-06-01)

Cerebral inflammatory amyloid angiopathy: response to treatment
by: João Roberto Ribeiro Pimenta, et al.
Published: (2025-08-01)

Impacts of the COVID-19 Pandemic on the CODE ST-Segment Elevation Myocardial Infarction Program: A Quantitative and Qualitative Analysis
by: Eka Ginanjar, et al.
Published: (2024-04-01)

ANALYSIS OF NURSING CARE IN NSTEMI PATIENTS WITH THE APPLICATION OF DEEP BREATHING RELAXATION AND MURATTAL THERAPY TO OVERCOME THE PROBLEM OF ACUTE PAIN
by: Kartika Milaningrum, et al.
Published: (2024-12-01)

Hypoxic Liver Injury as Predictor of Major Adverse Cardiac Events in Acute Myocardial Infarction patients admitted to Intensive Coroner Care Unit of Cipto Mangunkusumo National General Hospital
by: Muhadi, et al.
Published: (2018-09-01)

Reduced protein solubility – cause or consequence in amyloid disease?
by: Max Lindberg, et al.
Published: (2025-01-01)

Amyloid tumor of the breast
by: Makiko Mori, et al.
Published: (2019-02-01)

Amyloid-beta 40 as a biomarker of cognitive impairment in acute ischemic stroke
by: Aleksey A. Kulesh, et al.
Published: (2017-10-01)

Diagnosis, pathomechanisms and therapy of cerebral amyloid angiopathy-related inflammation (CAA-ri)
by: Rebecca M. Seifert, et al.
Published: (2025-04-01)

Positron Emission Tomography in Cerebral Amyloid Angiopathy: A Scoping Review
by: Marialuisa Zedde, et al.
Published: (2025-04-01)

Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol
by: Jimin Kim, et al.
Published: (2025-01-01)

Brazilian consensus for diagnosis, management and treatment of transthyretin familial amyloid polyneuropathy
by: Marcus Vinicius Pinto, et al.

Cerebral Amyloid Angiopathy Related Inflammation: A Single-Center Case Series Analysis
by: Syed Zahid Ali, et al.
Published: (2025-04-01)

Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy
by: Shiwani Randhawa, et al.
Published: (2025-04-01)

Evaluating Serum Amyloid A as a Biomarker in Preeclampsia
by: Montadhar K. Sultan, et al.
Published: (2025-03-01)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
by: Niklas Mattsson‐Carlgren, et al.
Published: (2021-05-01)

New insights into the 17β-hydroxysteroid dehydrogenase type 10 and amyloid-β 42 derived cytotoxicity relevant to Alzheimer’s disease
by: Aneta Houfková, et al.
Published: (2025-07-01)

Amyloid-β Inhibiting Peptides: An Innovative Strategy for Alzheimer’s Disease Treatment
by: Sajjad Molavipordanjani, et al.
Published: (2023-11-01)

Recent Advances in Amyloids Structural Studies and Thin Film Applications
by: Eugenia Pechkova, et al.
Published: (2025-07-01)